Kirsten Flowers - 06 Jan 2022 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Director
Signature
/s/ Robert Ticktin, by power of attorney
Issuer symbol
PMVP
Transactions as of
06 Jan 2022
Net transactions value
$0
Form type
4
Filing time
10 Jan 2022, 16:25:06 UTC
Previous filing
10 Jan 2022
Next filing
28 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Options Exercise $0 +32,677 $0.000000 32,677 06 Jan 2022 Common Stock 32,677 $19.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest in 36 equal monthly installments beginning on February 6, 2022.